Opaleye Management’s Ventyx Biosciences VTYX Stock Holding History

Opaleye Management’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-251,932	Closed	-$2.27M	–	62
2025 Q4	$2.27M	Buy	+251,932	New	+$1.88M	0.3%	42
2025 Q2	–	Sell	-190,000	Closed	-$219K	–	49
2025 Q1	$219K	Sell	190,000 -90,000	-32%	-$155K	0.05%	44
2024 Q4	$613K	Buy	+280,000	New	+$635K	0.11%	36
2024 Q3	–	Sell	-1,190,000	Closed	-$2.75M	–	56
2024 Q2	$2.75M	Sell	1,190,000 -95,000	-7%	-$395K	0.63%	38
2024 Q1	$7.07M	Buy	1,285,000 +145,000	+13%	+$663K	1.54%	21
2023 Q4	$2.82M	Buy	+1,140,000	New	+$10.8M	0.75%	33

Other funds holding VTYX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Opaleye Management's VTYX Position: Q1 2026 in Review

Opaleye Management sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 251,932 shares — an estimated $2.27M sold.

Opaleye Management first reported a position in VTYX in Q4 2023 and held it in 6 quarters. The position peaked at $7.07M in Q1 2024. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

Opaleye Management reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
Opaleye Management sold 251,932 Ventyx Biosciences shares in Q1 2026, an estimated $2.27M.
Opaleye Management first reported a position in Ventyx Biosciences in Q4 2023 and held it in 6 quarters.
Opaleye Management's Ventyx Biosciences position peaked at $7.07M in Q1 2024.
1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Opaleye Management's 13F filing for Q1 2026, filed 15 May 2026.